Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Wexford › NPI 1700913456
Physician

Lodico, Mark

Lodico, Mark was paid $212K by Medicaid between Nov 2020 and Nov 2024, across 18 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.

33Billing provider infoLODICO, MARK
WEXFORD, PA 15090
33aNPI1700913456assigned 02/28/2007
28Total paid$212K
24GClaims7,280
24DCodes billed18
24AFirst – last monthNov 2020 – Nov 2024
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in Pennsylvania

Rank by total paid#7 of 72
Median peer was paid$11K
This provider vs. median20×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020346$8K
20212,600$88K
20221,830$53K
20231,138$29K
2024incomplete1,366$34K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 41% 2,390 2,377 $88K
64635 17% 226 203 $37K
64483 17% 384 382 $36K
64493 8.3% 312 287 $18K
99152 3.2% 837 801 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.2% 110 110 $7K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 2.9% 730 712 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.8% 60 60 $4K
95886 1.6% 43 24 $3K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1.4% 29 29 $3K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity <1% 75 75 $2K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 12 12 $1K
6 more codes
64495 <1% 46 $384.78
77003 <1% 19 $165.96
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 820 $162.79
J3010 Injection, fentanyl citrate, 0.1 mg <1% 298 $128.88
64494 <1% 76 $102.87
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 813 $55.22

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.